Evidence map›Paper›PMID 42294908›Full record

ReviewJournal of virology2026

Alphavirus replicase and regulatory RNA elements in host interactions and viral vector engineering.

Dan T Boghici, Danni Yong, Silvia M Vidal, GuanQun Liu

Abstract readReview
In one paragraph

Review in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dan T BoghiciDepartment of Human Genetics, McGill University, Montreal, Quebec, Canada.
Danni YongThe McGill Research Centre on Complex Traits, Montreal, Quebec, Canada.
Silvia M VidalDepartment of Human Genetics, McGill University, Montreal, Quebec, Canada.
GuanQun LiuThe McGill Research Centre on Complex Traits, Montreal, Quebec, Canada.ORCID 0000-0003-2520-7625

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alphavirus-derived vector systems have been used for heterologous gene expression for nearly four decades, providing foundational insights into RNA virus replication, host interactions, and genome engineering. The recent success of conventional mRNA vaccines has intensified interest in leveraging the alphavirus replicase and its associated conserved sequence elements (CSEs) to develop self-amplifying mRNA (sa-mRNA) platforms characterized by more sustained antigen expression and dose-sparing. In this minireview, we summarize key advances that define the coordinated functions of the nonstructural proteins and CSEs in viral RNA synthesis and host modulation. We then contextualize the developmental milestones of alphavirus replicons that underpin modern sa-mRNA technologies. We further discuss emerging strategies to engineer replicase functions and RNA architecture in different sa-mRNA applications, while outlining critical gaps in alphavirus biology that currently constrain rational sa-mRNA design. Renewed investigation of nonstructural proteins and CSEs will accelerate optimization of next-generation sa-mRNA platforms and reinvigorate fundamental studies of alphavirus replication, evolution, and host adaptation.

Indexed as

AlphavirusGenetic VectorsHost Microbial InteractionsRNA-Dependent RNA PolymeraseRNA, ViralViral Replicase Complex ProteinsAnimalsGenetic EngineeringHumansRNA, MessengerRNA ReplicationViral Nonstructural ProteinsVirus ReplicationRNA-Dependent RNA PolymeraseRNA, MessengerRNA, ViralViral Nonstructural ProteinsViral Replicase Complex Proteinsalphavirusesgene therapyimmunotherapyinnate immunityself-amplifying RNAvaccinesviral vectors

Identifiers

PMID42294908
PMCPMC13386960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.